Nam Shin

Chief Executive Officer (CEO)

Nam Shin, Chief Executive Officer with over twenty years of experience working in the IVD Point of Care and pharmaceutical industry. Nam was previously the President & the CEO of Polaris BioSolution, Inc. He has worked at both Alfa Scientific and Princeton BioMeditech Corporation as executive leader of Operations and New Product Development. Nam has also worked in the Strategy Office of Hanil Synthetic Fiber Group.

Seungryoul Ahn

Vice President of Finance and Administration

Seungryoul Ahn, VP of Finance and Administration, is in charge of managing Finance, Accounting, Human Resources, and Information Systems as Vice President of Finance and Administration. Seungryoul is highly professional and skilled in all aspects of accounting, financial operations, and international business trade. He has several years of working experiences at Korean-based global companies such as Hyosung America and Samsung Techwin America. He received a Master Degree in Accountancy from the University of Illinois at Urbana-Champaign and second Master Degree in Management Information System (MIS) from the University of Arkansas at Little Rock.

Elizabeth Shin

Vice President of Product Development

Elizabeth Shin, VP of Product Development, leads Nexus Dx Product and Development department. She has over 20 years of experience in Immunoassay development on a multitude of platforms. Elizabeth has a Master of Science in Biochemistry from Yonsei University, Seoul, Korea.


Daniel Johnson

Sr. Director of Information Technologies

John Nguyen

Director of Technical Operations

Richard Ortiz

Sr. Accounting Manager

Greg Hamilton

Sr. Manufacturing Manager